297
Views
88
CrossRef citations to date
0
Altmetric
Review

A review on nanosystems as an effective approach against infections of Staphylococcus aureus

, , , , , , , & show all
Pages 7333-7347 | Published online: 09 Nov 2018

References

  • von EiffCBeckerKMachkaKStammerHPetersGNasal carriage as a source of Staphylococcus aureus bacteremia. Study GroupN Engl J Med20013441111611136954
  • ChambersHFThe changing epidemiology of Staphylococcus aureus?Emerg Infect Dis20017217818211294701
  • RasmussenGMoneckeSBrusOEhrichtRSöderquistBLong term molecular epidemiology of methicillin-susceptible Staphylococcus aureus bacteremia isolates in SwedenPLoS One2014912e11427625479442
  • PosadowskaUBrzychczy-WłochMPamułaEPerlTMCullenJJWenzelRPGentamicin loaded PLGA nanoparticles as local drug delivery system for the osteomyelitis treatmentActa Bioeng Biomech2015173414826687562
  • GordonRJLowyFDPathogenesis of methicillin-resistant Staphylococcus aureus infectionClin Infect Dis200846Suppl 5S350S35918462090
  • ConlonBPStaphylococcus aureus chronic and relapsing infections: evidence of a role for persister cellsBioessays2014361099199625100240
  • ZhouJFangTWangYThe controlled release of vancomycin in gelatin/β-TCP composite scaffoldsJ Biomed Mater Res2012100A922952301
  • BanburyMKExperience in prevention of sternal wound infections in nasal carriers of Staphylococcus aureusSurgery20031345 SupplS18S2214647029
  • MichaelIOGabrielOEPattern of renal diseases in children in mid-western zone of NigeriaSaudi J Kidney Dis Transpl200314453954417657132
  • BoucherHWTalbotGHBenjaminDK10 x ′20 Progress– development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaClin Infect Dis201356121685169423599308
  • JagielskiTPuaczELisowskiAShort communication: antimicrobial susceptibility profiling and genotyping of Staphylococcus aureus isolates from bovine mastitis in PolandJ Dairy Sci201497106122612825087034
  • MelchiorMBVaarkampHFink-GremmelsJBiofilms: a role in recurrent mastitis infections?Vet J2006171339840716624706
  • HalasaTHuijpsKØsteråsOHogeveenHEconomic effects of bovine mastitis and mastitis management: a reviewVet Q2007291183117471788
  • LoiselleMCSterCTalbotBGImpact of postpartum milking frequency on the immune system and the blood metabolite concentration of dairy cowsJ Dairy Sci20099251900191219389948
  • ClementSVaudauxPFrancoisPEvidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitisJ Infect Dis200519261023102816107955
  • KerrnMBStruveCBlomJFrimodt-MøllerNKrogfeltKAIntracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated miceJ Antimicrob Chemother200555338338615681580
  • MonackDMMuellerAFalkowSPersistent bacterial infections: the interface of the pathogen and the host immune systemNat Rev Microbiol20042974776515372085
  • FreemanAFHollandSMPersistent bacterial infections and primary immune disordersCurr Opin Microbiol2007101707517208513
  • PrajsnarTKCunliffeVTFosterSJRenshawSAA novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogensCell Microbiol200810112312232518715285
  • LöfflerBTuchscherrLNiemannSPetersGStaphylococcus aureus persistence in non-professional phagocytesInt J Med Microbiol2014304217017624365645
  • SpezialePPietrocolaGRindiSStructural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the hostFuture Microbiol20094101337135219995192
  • ZecconiAScaliFStaphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseasesImmunol Lett20131501–2122223376548
  • ClarkeSRBrummellKJHorsburghMJIdentification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriageJ Infect Dis200619381098110816544250
  • GarzoniCKelleyWLStaphylococcus aureus: new evidence for intracellular persistenceTrends Microbiol2009172596519208480
  • FosterTJGeogheganJAGaneshVKHöökMAdhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureusNat Rev Microbiol2014121496224336184
  • BankTLDosenAGieseRFHaaseEMSojarHTAtomic force spectroscopy evidence of non-specific adhesion of Aggregatibacter actino-mycetemcomitansJ Nanosci Nanotechnol201111108450845622400208
  • HarraghyNHussainMHaggarAThe adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein EapMicrobiology2003149Pt 102701270714523103
  • FraunholzMSinhaBIntracellular Staphylococcus aureus: live-in and let dieFront Cell Infect Microbiol201224322919634
  • TorresVJPishchanyGHumayunMSchneewindOSkaarEPStaphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilizationJ Bacteriol2006188248421842917041042
  • RasmussenGMoneckeSBrusOEhrichtRSöderquistBLong term molecular epidemiology of methicillin-susceptible Staphylococcus aureus bacteremia isolates in SwedenPLoS One2014912e11427625479442
  • WilkeGABubeck WardenburgJWardenburgJBRole of a dis-integrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injuryProc Natl Acad Sci U S A201010730134731347820624979
  • GroszMKolterJPaprotkaKCytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin αCell Microbiol201416445146524164701
  • GarzoniCKelleyWLStaphylococcus aureus: new evidence for intracellular persistenceTrends Microbiol2009172596519208480
  • KahlBCSmall colony variants (SCVs) of Staphylococcus aureus – a bacterial survival strategyInfect Genet Evol20142151552223722021
  • TuchscherrLMedinaEHussainMStaphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infectionEMBO Mol Med20113312914121268281
  • TuchscherrLGeraciJLöfflerBStaphylococcus aureus regulator Sigma B is important to develop chronic infections in hematogenous murine osteomyelitis modelPathogens201763E3128714889
  • ProctorRABalwitJMVesgaOVariant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infectionsInfect Agents Dis1994363023127889317
  • SendiPProctorRAStaphylococcus aureus as an intracellular pathogen: the role of small colony variantsTrends Microbiol2009172545819162480
  • BuiLMGKiddSPA full genomic characterization of the development of a stable small colony variant cell-type by a clinical Staphylococcus aureus strainInfect Genet Evol20153634535526458527
  • TuchscherrLHeitmannVHussainMStaphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistenceJ Infect Dis201020271031104020715929
  • OuJJDrillingAJCooksleyCReduced innate immune response to a Staphylococcus aureus small colony variant compared to its wild-type parent strainFront Cell Infect Microbiol2016618728083514
  • SerraRGrandeRBuffoneGExtracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokinesInt Wound J2016131535824618232
  • LooneyWJSmall-colony variants of Staphylococcus aureusBr J Biomed Sci200057431732211204864
  • BesierSLudwigAOhlsenKBradeVWichelhausTAMolecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureusInt J Med Microbiol2007297421722517412637
  • AmatoSMFazenCHHenryTCThe role of metabolism in bacterial persistenceFront Microbiol201457024624123
  • BassegodaAIvanovaKRamonETzanovTStrategies to prevent the occurrence of resistance against antibiotics by using advanced materialsAppl Microbiol Biotechnol201810252075208929392390
  • OyamaTMiyazakiMYoshimuraMTakataTOhjimiHJimiSBiofilm-forming methicillin-resistant Staphylococcus aureus survive in kupffer cells and exhibit high virulence in miceToxins201687198
  • ArmsteadALLiBNanomedicine as an emerging approach against intracellular pathogensInt J Nanomedicine201163281329322228996
  • LimbertMIsertDKleselNAntibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporinAntimicrob Agents Chemother199135114192014969
  • BrionesEColinoCILanaoJMDelivery systems to increase the selectivity of antibiotics in phagocytic cellsJ Control Release2008125321022718077047
  • Pinto-AlphandaryHAndremontACouvreurPTargeted delivery of antibiotics using liposomes and nanoparticles: research and applicationsInt J Antimicrob Agents200013315516810724019
  • TaberWHMuellerJPMillerPFBacterial uptake of aminoglycoside antibioticsMicro Rev1987514439457
  • BuiLMConlonBPKiddSPAntibiotic tolerance and the alternative lifestyles of Staphylococcus aureusEssays Biochem2017611717928258231
  • Gómez CasanovaNSiller RuizMMuñoz BellidoJLMechanisms of resistance to daptomycin in Staphylococcus aureusRev Esp Quimioter201730639139629082727
  • GardeteSTomaszAMechanisms of vancomycin resistance in Staphylococcus aureusJ Clin Invest201412472836284024983424
  • BeckerKBallhausenBKöckRKriegeskorteAMethicillin resistance in Staphylococcus isolates: the “mec alphabet” with specific consideration of mecC, a mec homolog associated with zoonotic S. aureus lineagesInt J Med Microbiol2014304779480425034857
  • DeurenbergRHStobberinghEEThe molecular evolution of hospital-and community-associated methicillin-resistant Staphylococcus aureusCurr Mol Med20099210011519275621
  • Hall-StoodleyLStoodleyPEvolving concepts in biofilm infectionsCell Microbiol20091171034104319374653
  • SinghRRayPDasASharmaMRole of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro studyJ Med Microbiol200958Pt 81067107319528167
  • ParkSBSteadmanCSChaudhariAAProteomic analysis of antimicrobial effects of pegylated silver coated carbon nanotubes in Salmonella enterica serovar TyphimuriumJ Nanobiotechnology20181613129587743
  • YazarEBasALBirdaneYOYaparKElmasMTrasBDetermination of intracellular (neutrophil and monocyte) concentrations of free and liposome encapsulated ampicillin in sheepVeterinární Medicína20125125154
  • BastariKArshathMNgZHA controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilmJ Mater Sci Mater Med201425374775724370968
  • ThomasNThornCRichterKThierryBPrestidgeCEfficacy of poly-lactic-co-glycolic acid micro- and nanoparticles of ciprofloxacin against bacterial biofilmsJ Pharm Sci2016105103115312227519649
  • MayaSIndulekhaSSukhithasriVEfficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureusInt J Biol Macromol201251439239922705573
  • JiangXHZhouWMHeYZWangYLvBWangXMEffects of lipopeptide carboxymethyl chitosan nanoparticles on Staphylococcus aureus biofilmJ Biol Regul Homeost Agents201731373774328956426
  • SutherlandIWThe biofilm matrix – an immobilized but dynamic microbial environmentTrends Microbiol20019522222711336839
  • ZhouTHSuMShangBCNano-hydroxyapatite/β-tricalcium phosphate ceramics scaffolds loaded with cationic liposomal ceftazidime: preparation, release characteristics in vitro and inhibition to Staphylococcus aureus biofilmsDrug Dev Ind Pharm201238111298130422257380
  • RanjanAPothayeeNSeleemMNAntibacterial efficacy of core-shell nanostructures encapsulating gentamicin against an in vivo intracellular Salmonella modelInt J Nanomed20094289297
  • RanjanAPothayeeNVadalaTPEfficacy of amphiphilic core-shell nanostructures encapsulating gentamicin in an in vitro salmonella and listeria intracellular infection modelAntimicrob Agents Chemother20105483524352620516284
  • HuDLiHWangBSurface-adaptive gold nanoparticles with effective adherence and enhanced photothermal ablation of methicillin-resistant Staphylococcus aureus biofilmACS Nano20171199330933928806528
  • AlvesMMBouchamiOTavaresANew insights into antibiofilm effect of a nanosized ZnO coating against the pathogenic methicillin resistant Staphylococcus aureusACS Appl Mater Interfaces2017934281572816728782933
  • MillerKPWangLChenYPPellechiaPJBenicewiczBCDechoAWEngineering nanoparticles to silence bacterial communicationFront Microbiol2015618925806030
  • ImbuluzquetaEDrug delivery systems for potential treatment of intracellular bacterial infectionsFront Biosci2010151397417
  • HuaLHilliardJJShiYAssessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumoniaAntimicrob Agents Chemother20145821108111724295977
  • ChakrabortySPSahuSKMahapatraSKNanoconjugated vancomycin: new opportunities for the development of anti-VRSA agentsNanotechnology2010211010510320154376
  • GuptaPVNirwaneAMBelubbiTNagarsenkerMSPulmonary delivery of synergistic combination of fluoroquinolone antibiotic complemented with proteolytic enzyme: a novel antimicrobial and antibiofilm strategyNanomedicine20171372371238428648640
  • HsuCYYangSCSungCTWengYHFangJYAnti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targetingInt J Nanomedicine2017128227823829184410
  • PornpattananangkulDZhangLOlsonSBacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infectionJ Am Chem Soc2011133114132413921344925
  • DeesCSchultzRDThe mechanism of enhanced intraphagocytic killing of bacteria by liposomes containing antibioticsVet Immunol Immunopathol19902421351462336788
  • AhaniEMontazerMToliyatTMahmoudi RadMHarifiTPreparation of nano cationic liposome as carrier membrane for polyhexam-ethylene biguanide chloride through various methods utilizing higher antibacterial activities with low cell toxicityJ Microencapsul201734212113128609225
  • BaşALSimşekAErganişOCorluMBasALSimsekAEfficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitroDtsch Tierarztl Wochenschr2005112621922316028487
  • BaşLASimşekACorluMYazarEElmasMDeğimZGDetermination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in anatolian shepherd dog monocytesJ Vet Med B Infect Dis Vet Public Health200249628929312241030
  • ZhaoGHuCXueYIn vitro evaluation of chitosan-coated liposome containing both coenzyme Q10 and alpha-lipoic acid: cytotoxicity, antioxidant activity, and antimicrobial activityJ Cosmet Dermatol201817225826228722258
  • NigatuASAsharHSethuramanSNElastin-like polypeptide incorporated thermally sensitive liposome improve antibiotic therapy against musculoskeletal bacterial pathogensInt J Hyperthermia201834220120829278945
  • XieSYangFTaoYEnhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular SalmonellaSci Rep201771411028646211
  • UskokovićVDesaiTASimultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureusMater Sci Eng C Mater Biol Appl20143721022224582242
  • ChouJValenzuelaSGreenDWAntibiotic delivery potential of nano- and micro-porous marine structure-derived β-tricalcium phosphate spheres for medical applicationsNanomedicine2014981131113924471502
  • AkbariVAbediDPardakhtyASadeghi-AliabadiHCiprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluationJ Nanopart Res2013154114
  • GeiserMUpdate on macrophage clearance of inhaled micro- and nanoparticlesJ Aerosol Med Pulm Drug Deliv201023420721720109124
  • XieSTaoYPanYBiodegradable nanoparticles for intracellular delivery of antimicrobial agentsJ Control Release201418710111724878179
  • GenestetCBernard-BarretFHodilleEAntituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Myco-bacterium tuberculosis-infected macrophagesTuberculosis (Edinb)2018111677030029917
  • SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
  • SémiramothNdi MeoCZouhiriFSelf-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infectionsACS Nano2012653820383122482704
  • AllenTMAustinGAChonnALinLLeeKCUptake of liposomes by cultured mouse bone marrow macrophages: influence of lipo-some composition and sizeBiochim Biophys Acta19911061156641995057
  • CouvreurPVauthierCNanotechnology: intelligent design to treat complex diseasePharm Res20062371417145016779701
  • BeningoKAWangYFc-receptor-mediated phagocytosis is regulated by mechanical properties of the targetJ Cell Sci2012115849856
  • KalhapureRSSonawaneSJSikwalDRSolid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSAColloids Surf B Biointerfaces201513665165826492156
  • KalhapureRSMocktarCSikwalDRIon pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticlesColloids Surf B Biointerfaces201411730331124667076
  • LiYSuTZhangYHuangXLiJLiCLiposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infectionDrug Deliv201522562763724471983
  • LiuXLiZWangXNovel antimicrobial peptide-modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureusInt J Nanomedicine2016116781679428008253
  • ZhangDKongYYSunJHCo-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistanceInt J Nanomedicine2017122081210828356731
  • KalhapureRSJadhavMRambharoseSpH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycinColloids Surf B Biointerfaces201715865065728763772
  • KalhapureRSSikwalDRRambharoseSEnhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipidNanomedicine20171362067207728434930
  • AuroreVCaldanaFBlanchardMSilver-nanoparticles increase bactericidal activity and radical oxygen responses against bacterial pathogens in human osteoclastsNanomedicine201814260160729155361
  • RichterKThomasNZhangGDeferiprone and gallium- protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variantsFront Cell Infect Microbiol2017728028690982
  • WangXFZhangSLZhuLYEnhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivoVet J2012191111512021900026
  • XieYLiuYYangJGold nanoclusters for targeting MRSA in vivoAngew Chem Int Ed Eng2018571539583962
  • JadhavMKalhapureRSRambharoseSNovel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic deliveryChem Phys Lipids2018212122529305156
  • GuoJZhouHWangJNano vanadium dioxide films deposited on biomedical titanium: a novel approach for simultaneously enhanced osteogenic and antibacterial effectsArtif Cells Nanomed Biotechnol201821117
  • ZhaoZYanRYiXBacteria-activated theranostic nanoprobes against methicillin-resistant Staphylococcus aureus infectionACS Nano20171154428443828350437
  • NimalTRBaranwalGBavyaMCBiswasRJayakumarRAnti-staphylococcal activity of injectable nano tigecycline/chitosan-PRP composite hydrogel using Drosophila melanogaster model for infectious woundsACS Appl Mater Interfaces2016834220742208327508491
  • DengYKizerMRadaMIntracellular delivery of nano-materials via an inertial microfluidic cell hydroporatorNano Lett20181842705271029569926
  • KaprelyantsASGottschalJCKellDBDormancy in non-sporulating bacteriaFEMS Microbiol Rev1993103–42712868318260
  • AnisimovaYVGelperinaSIPeloquinCAHeifetsLBNanoparticles as antituberculosis drugs carriers: effect on activity against myco-bacterium tuberculosis in human monocyte-derived macrophagesJ Nanopart Res200022165171
  • LinPLFlynnJLUnderstanding latent tuberculosis: a moving targetJ Immunol20101851152220562268
  • MaTShangBCTangHNano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilmsJ Biomater Sci Polym Ed201122121669168121605505
  • PeiYMohamedMFSeleemMNYeoYParticle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophagesJ Control Release201726713314328797580
  • MaoCXieXLiuXThe controlled drug release by pH-sensitive molecularly imprinted nanospheres for enhanced antibacterial activityMater Sci Eng C Mater Biol Appl201777849128532100
  • XueYXiaXYuBA green and facile method for the preparation of a pH-responsive alginate nanogel for subcellular delivery of doxorubicinRSC Adv20155907341673423
  • MurakamiMCabralHMatsumotoYImproving drug potency and efficacy by nanocarrier-mediated subcellular targetingSci Transl Med2011364ra2
  • AshbyMPetkovaAHilpertKCationic antimicrobial peptides as potential new therapeutic agents in neonates and children: a reviewCurr Opin Infect Dis201427325826724722240
  • Lopez CascalesJJGarroAPorassoRDEnrizRDThe dynamic action mechanism of small cationic antimicrobial peptidesPhys Chem Chem Phys20141639216942170525198294
  • GeorgeSKishenAAugmenting the antibiofilm efficacy of advanced noninvasive light activated disinfection with emulsified oxidizer and oxygen carrierJ Endod20083491119112318718378
  • GeorgeSKishenAPhotophysical, photochemical, and photobiological characterization of methylene blue formulations for light-activated root canal disinfectionJ Biomed Opt200712303402917614737
  • ShresthaACordovaMKishenAPhotoactivated polycationic bioactive chitosan nanoparticles inactivate bacterial endotoxinsJ Endod201541568669125637193
  • ZhangYZhangJChenWErythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infectionJ Control Release201726318519128087406